CJC-1295 (No DAC) & Ipamorelin Blend 10mg 5/5

This formulation combines two research peptides—CJC-1295 (No DAC) and Ipamorelin—each at 5mg, for a total of 10mg per vial. Both peptides are frequently used in experimental studies focused on growth hormone regulation, hypothalamic-pituitary signaling, and peptide stability.

This vial contains a sterile lyophilized blend suitable for laboratory and investigative purposes only. CJC-1295 (No DAC) is a tetrasubstituted peptide analog of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective ghrelin receptor agonist studied in tandem for their synergistic properties in scientific models. This product is strictly not for human or veterinary use.

Key Benefits:

• Investigational blend for growth hormone secretion studies in controlled lab settings 
• Designed to explore pulsatile GH release through dual-pathway peptide stimulation 
• Lyophilized format ensures long-term peptide stability prior to reconstitution 
• Balanced 5mg:5mg ratio for standardized experimental dosing 
• Free from fillers, preservatives, or stabilizers 

Scientific Context:

CJC-1295 (No DAC) is a modified analog of GHRH that retains a short half-life and is studied for its ability to induce natural pulsatile growth hormone release without disrupting feedback mechanisms. Unlike the DAC version, CJC-1295 No DAC does not bind to albumin, resulting in a shorter, more controlled duration of action—favorable in many research designs.

Ipamorelin is a pentapeptide known for its selectivity toward the growth hormone secretagogue receptor (GHSR). It has been studied in both rodent and in vitro models for its role in stimulating growth hormone (GH) secretion without significantly altering prolactin or cortisol levels, making it of interest for targeted hormone pathway investigations.

The combination of these two peptides is studied for potential additive effects in GH signaling pathways, though all research remains preclinical and non-therapeutic in nature.

Ingredients / Composition:

• Active Ingredients: 
  • CJC-1295 (No DAC) – 5mg 
  • Ipamorelin – 5mg 
• Form: Sterile lyophilized powder 
• Total Content per Vial: 10mg (5mg + 5mg) 
• Purity: ≥99% (independently tested via HPLC/MS) 
• Additives: None 
• Packaging: Single-use sealed glass vial 

How to Use / Reconstitution:

• Intended for Research Use Only. Not for human or veterinary use. 
• Reconstitute with bacteriostatic water using aseptic technique in sterile environments 
• Suggested concentration: 2–5ml of bacteriostatic water per vial depending on lab protocol 
• After reconstitution, refrigerate at 2–8°C and use within 20–30 days 
• Avoid repeated freeze-thaw cycles to maintain peptide integrity 

All usage must follow institutional biosafety and handling standards. Do not use for any purpose outside of approved laboratory testing.

Quality & Testing:

Produced in a GMP-compliant and ISO-certified laboratory. Each peptide batch undergoes third-party testing to verify:

• Molecular identity and peptide sequence
  
• Purity (≥99%) 
• Endotoxin levels and sterility 
• Stability and pH range after reconstitution 

A Certificate of Analysis (COA) is available for each lot and can be requested by qualified research personnel.

Safety & Disclaimers:

For Research Use Only. Not for human or veterinary use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Any misuse, human consumption, or off-label application is strictly prohibited and may violate federal law.